Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer

Authors:

Abstract
No abstract available
Funding Information
  • Shenyang Pharmaceutical University
  • China Postdoctoral Science Foundation
  • Department of Science and Technology of Liaoning Province
  • National Health and Family Planning Commission of the People's Republic of China
  • Ministry of Science and Technology of the People's Republic of China

This publication has 39 references indexed in Scilit: